Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim

No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura

(2013) G. D'Arena et al.   BLOOD

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

(2013) M. Khellaf et al.   HAEMATOLOGICA

The biology of thrombopoietin and thrombopoietin receptor agonists

(2013) David J. Kuter   INTERNATIONAL JOURNAL OF HEMATOLOGY

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

(2012) W. Ghanima et al.   BLOOD

Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations

(2012) T. Aoki et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura

(2009) Mark D. Danese et al.   AMERICAN JOURNAL OF HEMATOLOGY

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Impact of ITP on physician visits and workplace productivity

(2009) Michael D. Tarantino et al.   CURRENT MEDICAL RESEARCH AND OPINION

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP

(2008) J. B. Bussel et al.   BLOOD

Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

(2008) Susan D Mathias et al.   Health and Quality of Life Outcomes

Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal

(2008) M. A. FEUDJO-TEPIE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

(2008) David J Kuter et al.   LANCET

Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura

(2007) Robert McMillan et al.   AMERICAN JOURNAL OF HEMATOLOGY